Synopsis
Motivation:
Goals:
Approach:
Results:
303-03-006
ISMRM Abstract
Arterial Spin Labeling Reveals Hyperperfusion Linked to Cognitive Performance in Treated Glioma Survivors.
Accepted
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
Log inReferences
1. J. A. T. Raj, J. Shah, S. Ghanekar, G. John, J. S. Goda, and A. Chatterjee, “Pharmacological and therapeutic innovation to mitigate radiation-induced cognitive decline (RICD) in brain tumor patients,” Cancer Lett, vol. 620, p. 217700, Jun. 2025, doi: 10.1016/J.CANLET.2025.217700. [doi]
2. B. Smith-Salzberg et al., “The effects of radiation therapy on the brain: implications for management,” Chin Clin Oncol, vol. 14, no. 3, pp. 32–32, Jun. 2025, doi: 10.21037/CCO-24-125/COIF. [doi]
3. C. Qin, S. Qiu, H. Wang, F. Duan, D. Wu, and X. Leng, “A Study on the correlation between brain functional and structural changes and altered cognitive function after radiotherapy for nasopharyngeal carcinoma,” 2022, doi: 10.52547/ijrr.20.3.16. [doi]
4. B. D. Allen and C. L. Limoli, “Breaking barriers: Neurodegenerative repercussions of radiotherapy induced damage on the blood-brain and blood-tumor barrier,” Free Radic Biol Med, vol. 178, pp. 189–201, Jan. 2022, doi: 10.1016/J.FREERADBIOMED.2021.12.002. [doi]
5. C. Andrade, “Z Scores, Standard Scores, and Composite Test Scores Explained,” Indian J Psychol Med, vol. 43, no. 6, pp. 555–557, Nov. 2021, doi: 10.1177/02537176211046525. [doi]
6. S. J. M. Rijnen et al., “Evaluation of Normative Data of a Widely Used Computerized Neuropsychological Battery: Applicability and Effects of Sociodemographic Variables in a Dutch Sample,” Assessment, vol. 27, no. 2, p. 373, Mar. 2017, doi: 10.1177/1073191117727346. [doi]
7. J. Pinto et al., “Calibration of arterial spin labeling data—potential pitfalls in post‐processing,” Magn Reson Med, vol. 83, no. 4, p. 1222, Apr. 2019, doi: 10.1002/MRM.28000. [doi]
8. H. J. M. M. Mutsaerts et al., “ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies,” Neuroimage, vol. 219, p. 117031, Oct. 2020, doi: 10.1016/J.NEUROIMAGE.2020.117031. [doi]
9. B. Alexander et al., “Desikan-Killiany-Tourville Atlas compatible version of m-CRIB neonatal parcellated whole brain atlas: The m-Crib 2.0,” Front Neurosci, vol. 13, no. FEB, p. 425778, Feb. 2019, doi: 10.3389/FNINS.2019.00034/BIBTEX. [doi]
10. D. C. Alsop et al., “Recommended Implementation of Arterial Spin Labeled Perfusion MRI for Clinical Applications: A consensus of the ISMRM Perfusion Study Group and the European Consortium for ASL in Dementia,” Magn Reson Med, vol. 73, no. 1, p. 102, Jan. 2014, doi: 10.1002/MRM.25197. [doi]
11. M. Fahlström, E. Blomquist, T. Nyholm, and E. M. Larsson, “Perfusion Magnetic Resonance Imaging Changes in Normal Appearing Brain Tissue after Radiotherapy in Glioblastoma Patients may Confound Longitudinal Evaluation of Treatment Response,” Radiol Oncol, vol. 52, no. 2, p. 143, 2018, doi: 10.2478/RAON-2018-0022. [doi]
12. L. De Roeck et al., “Structural Network Hubs as Potential Organs at Risk in Glioma Patients After Radiation Therapy,” Int J Radiat Oncol Biol Phys, vol. 122, no. 3, pp. 631–642, Jul. 2025, doi: 10.1016/j.ijrobp.2025.03.019. [doi]
Cite this abstract
http://echo.ismrm.org/p/ISMRM2026/303-03-006